Knight Therapeutics | GUD - Interest Expense On Debt

Stock Price
6.14
Daily Change
0.04 0.66%
Monthly
-4.06%
Yearly
-0.49%
Q1 Forecast
5.95

Knight Therapeutics reported CAD2.37M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 0 0 Dec/2023
Aurora Cannabis CAD 2.22M 442K Sep/2025
Avita Medical AUD 1.25M 100K Jun/2025
Canopy Growth CAD 8.8M 938K Sep/2025
Cronos Group USD 0 7K Sep/2024
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 0 Dec/2025
IQVIA Holdings USD 193M 4M Dec/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Moderna USD 12.14B 12.13B Sep/2025
Omeros USD 4.05M 5.16M Sep/2024
Organon & Co USD 128M 3M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Tilray USD 6.7M 2.73M Jun/2025
Viatris USD 119.6M 0 Dec/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025